Therapeutic Benefit in Allergic Dermatitis Derived from the Inhibitory Effect of Byakkokaninjinto on the Migration of Plasmacytoid Dendritic Cells

<div>The effects of byakkokaninjinto on CCR7 expression in BMpDCs. The expression of CCR7 on BMpDCs treated with 0.1 mg/ml byakkokaninjinto (black line) or the vehicle (gray line) was detected by flow cytometry. Representative CCR7 expression data are represented by the line graph.</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Therapeutic Benefit in Allergic Dermatitis Derived from the Inhibitory Effect of Byakkokaninjinto on the Migration of Plasmacytoid Dendritic Cells 

Figure 3 | Therapeutic Benefit in Allergic Dermatitis Derived from the Inhibitory Effect of Byakkokaninjinto on the Migration of Plasmacytoid Dendritic Cells 